Company Filing History:
Years Active: 2015
Title: Innovations of Sharon A Kuruvilla: Pioneering Research in Nicotinic Acetylcholine Receptors
Introduction
Sharon A Kuruvilla is a notable inventor based in San Jose, CA, recognized for her contributions to the field of biochemistry and pharmacology. With a strong focus on understanding nicotinic acetylcholine receptors, she has developed innovative methods that hold significant potential for medical diagnostics and therapies. Her research aims to tackle diseases associated with these receptors, showcasing her commitment to advancing scientific knowledge.
Latest Patents
Sharon holds a patent titled "Labeled A4B2 ligands and methods therefor." This innovative patent includes compositions and methods designed to selectively bind to the α4β2 nicotinic acetylcholine receptor both in vitro and in vivo. The applications of these compounds are multifaceted, as they can be utilized for PET and SPECT analysis. Furthermore, the patent also covers the use of these compounds as antagonists, partial agonists, or agonists, which may be essential in treating various conditions linked to α4β2 receptor dysfunction.
Career Highlights
Sharon A Kuruvilla is affiliated with the University of California, where she has engaged in cutting-edge research and development. Her work is characterized by its innovative nature and has the potential to contribute significantly to therapeutic strategies involving neurotransmitter systems. Her focus on nicotinic acetylcholine receptors aligns with modern biomedical research aimed at enhancing human health.
Collaborations
In her pursuit of innovation, Sharon collaborates with esteemed colleagues in her field, including Jogeshwar Mukherjee. This collaboration emphasizes the importance of teamwork in scientific research and the sharing of insights that drive progress in developing new technologies and treatments.
Conclusion
Sharon A Kuruvilla exemplifies the spirit of innovation through her patent and research at the University of California. Her work on nicotinic acetylcholine receptors not only advances scientific understanding but also opens pathways for potential medical breakthroughs. As she continues to explore new frontiers in her field, Sharon remains a pivotal figure in the landscape of modern biochemistry and pharmacology.